文献速递炎症性肠病消化道肿瘤与早癌消化道出血

炎症性肠病患者结直肠癌术后静脉血栓栓塞风险

Risk of Venous Thromboembolism After Colorectal Cancer Surgery in Patients With and Without Inflammatory Bowel Disease.
PubMed 文献 · Am J Gastroenterol · 2025-09-03

基于丹麦全国登记(1996-2021)的队列研究纳入83950例首次结直肠癌手术患者,比较有/无炎症性肠病(IBD)者的静脉血栓栓塞(VTE)风险;IBD患者30天VTE风险1.5% vs 0.7%(aHR 1.61, 95%CI 0.86-3.01),活动期IBD及男性、60-69岁者关联更强,91-365天风险仍升高。

要点

  • IBD患者结直肠癌术后30天VTE风险为1.5%,无IBD者为0.7%。
  • 活动期IBD患者30天VTE风险关联最强(aHR 5.29)。
  • 术后91-365天IBD患者VTE风险仍持续升高。

核心结论

  • IBD患者结直肠癌术后VTE风险高于无IBD者,活动期及术前接受IBD治疗者关联更强,以溃疡性结肠炎为主。

研究设计与样本

  • 基于丹麦健康登记(1996-2021)的全国性队列研究,纳入83950例首次结直肠癌手术患者,以既往IBD诊断为暴露。

主要发现

  • 30天VTE风险IBD患者1.5%,无IBD者0.7%(aHR 1.61; 95%CI 0.86-3.01)。
  • 男性aHR 2.26(95%CI 1.06-4.82),60-69岁aHR 4.63(95%CI 1.88-11.39)。
  • 术前接受IBD治疗者aHR 1.95(95%CI 0.97-3.95),活动期疾病aHR 5.29(95%CI 1.69-16.56)。
  • 风险升高持续至术后91-365天。

临床怎么用

  • 对IBD结直肠癌术后患者应提高VTE警惕,尤其活动期及术前接受IBD治疗者。
  • 优化IBD疾病控制可能有助于降低术后VTE风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Inflammatory bowel disease (IBD) is associated with elevated postoperative mortality in patients undergoing colorectal cancer (CRC) surgery. Venous thromboembolism (VTE) may partially contribute to this elevated mortality. We investigated VTE risk in patients with and without IBD undergoing their first CRC surgery. METHODS: We conducted a population-based cohort study using Danish health registries (1996-2021), including all patients undergoing first-time CRC surgery (n = 83,950). Patients with a prior IBD diagnosis were defined as exposed. We calculated the 365-day cumulative risks of VTE and used Cox regression to compute adjusted hazard ratios (aHRs) with 95% confidence intervals (CIs). RESULTS: The 30-day VTE risk was 1.5% in patients with IBD and 0.7% in those without IBD (aHR 1.61; 95% CI 0.86-3.01). During this period, the strongest associations were observed among male patients (aHR 2.26; 95% CI 1.06-4.82), patients aged 60-69 years (aHR 4.63; 95% CI 1.88-11.39), those who had received IBD treatment before surgery (aHR 1.95; 95% CI 0.97-3.95), and patients with active disease (aHR 5.29; 95% CI 1.69-16.56). These associations were primarily driven by patients with ulcerative colitis. HRs remained elevated during 91-365 days. DISCUSSION: Patients with IBD are at elevated risk of VTE after CRC surgery compared with those without IBD. The strongest associations were observed in those who had received IBD treatment before surgery and in those with active disease, particularly patients with ulcerative colitis. These findings emphasize the need for increased VTE awareness and optimizing disease control in patients with high-risk IBD.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Kurt G, Troelsen FS, Veres K, et al. Risk of Venous Thromboembolism After Colorectal Cancer Surgery in Patients With and Without Inflammatory Bowel Disease. Am J Gastroenterol. 2025. PMID: 40900085. doi:10.14309/ajg.0000000000003761

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。